<p style="text-align: left; margin-left: .5in; text-indent: -.5in;"><span style="font-family: 'Times New Roman';"> Newer references relate primarily to ketogenic diets and their effects on cancer, diabetes, and other aspects of physiology/pathophysiology</span></p>
<p style="text-align: left; margin-left: .5in; text-indent: -.5in;"> </p>
<p><strong>Fine EJ</strong>, Segal-Isaacson CJ, Feinman R, Sparano J: Carbohydrate restriction in patients with advanced cancer: a protocol to assess safety and feasibility with an accompanying hypothesis. Commun Oncol 2008;5:22–2</p>
<p><strong>Fine EJ</strong><span style="text-decoration: underline;">,</span> Miao W, Koba W, Volek JS, Blaufox, MD: Chronic effects of dietary carbohydrate variation on <sup>18</sup>F-2, Fluoro 2,deoxy-glucose uptake in rodent heart. Nuclear Med Communications Sep 2009: 30(9):675-80</p>
<p><strong>Fine EJ</strong>, Miller A, Quadros EV, Sequeira JM, Feinman RD: Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2. Cancer Cell Intl 2009, 9:14 <span style="text-decoration: underline;">http://www.cancerci.com/content/9/1/14 </span></p>
<p><strong>Fine EJ</strong>, Segal-Isaacson CJ,Feinman RD, Herszkopf S, Romano MC, Tomuta N, Bontempo AF, Negassa A, Sparano JA: Targeting insulin inhibition as a metabolic therapy in advanced cancer: A pilot safety and feasibility dietary trial in ten patients. Nutrition (Elsevier) 2012: Oct;28(10):1028-35. doi:10.1016/j.nut<strong>.</strong>.05.001. Epub 2012 Jul 26.</p>
<p><strong>Fine EJ, </strong>Feinman RD<strong>: </strong>Insulin, carbohydrate restriction and cancer. Expert Reviews in Endocrinology and Metabolism. 2014,</p>
<p><strong>Fine EJ</strong>, Feinman R, Miller A: Acetoacetate is a metabolic inhibitor of cancer growth. FASEB Jl. 2015: <em>29 no. 1 Supplement 725.22</em></p>
<p style="text-align: left; margin-left: .5in; text-indent: -.5in;"> </p>
<p><span style="text-decoration: underline;">Older references mostly concerning renal function, hypertension diagnosis, nuclear medicine techniques,</span></p>
<p><span style="font-family: 'Times New Roman';"><span style="text-decoration: underline;">Fine EJ</span>, Axelrod M, Gorkin J, et al: Measurement of effective renal plasma flow: A comparison of methods. J.Nucl.Med. 28(9): 1393-1400, 1987.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> </span> <span style="font-family: 'Times New Roman';"> Kim D, <span style="text-decoration: underline;">Fine EJ</span>, Silver CE: Preoperative localization or parathyroid lesions using thallium technetium scintiscanning. Surg.</span> <span style="font-family: 'Times New Roman';">Gyn.Obstet. 105:212-216, 1987.</span></p>
<p><span style="font-family: 'Times New Roman';"> Fabry ME, Raganayagam V, <span style="text-decoration: underline;">Fine EJ</span>, Nagel RL, Holland S, Gore JC, and Kaul DK: Modelling sickle cell vaso-occlusion in the rat leg: Quantification of trapped sickle cells and correlation with 31-P metabolic 1H MRI changes. Proc.Natl.Acad.Sci. 86:3808-3812, 1989.</span></p>
<div>
<p style="text-align: justify;"> <span style="text-decoration: underline;"><span style="font-family: 'Times New Roman';">Fine EJ</span></span><span style="font-family: 'Times New Roman';"> and Blaufox MD: The Einstein/Cornell Collaborative Protocol to Assess Efficacya</span><span style="font-family: 'Times New Roman';">nd Methodology in Captopril Scintirenography: Early Results in Hypertensives Without </span><span style="font-family: 'Times New Roman';">Renovascular Hypertension. Amer.J.Hypertension 4:716S-720S,1991</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> Nally Jr.,JV, Chen C, <span style="text-decoration: underline;">Fine EJ</span>, Fommei E, Ghione S, Geyskes GG, Hoffer P, Sfakianakis G: Diagnostic Criteria of Renovascular Hypertension with Captopril Renography. AJH 4:749S-752S, 1991.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"><span style="font-weight: normal; line-height: normal; font-size: 7.0pt; font-variant: normal; font-style: normal; font-family: 'Times New Roman';"> </span></span><span style="font-family: 'Times New Roman';">Fabry ME, <span style="text-decoration: underline;">Fine EJ</span>, Rajanayagam V, Factor SM, Gore J, Sylla M, Nagel RL: Demonstration of Endothelial Adhesion of Sickle Cells In Vivo: A Distinct Role for Deformable SS Discocytes. Blood, 79:1602-1611, 1992.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> <span style="text-decoration: underline;">Fine EJ</span>, Blaufox MD, Bongiovanni J, Chun KJ, Heller S, Blumenfeld J: Exercise Renography in Untreated Patients with Essential Hypertension. J.Nucl.Med. 37:838-842; 1996</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> </span><span style="font-family: 'Times New Roman';"> Taylor Jr.A, Nally J, Aurell M, Blaufox MD, Dondi M, Dubovsky E, <span style="text-decoration: underline;">Fine EJ</span>, Fommei E, Geyskes G, Granerus G, Kahn D, Morton K, Oei H-Y, Russell C, Sfakianakis G, Fletcher J: Consensus Report on Ace Inhibitor Renography for Detecting Renovascular Hypertension. 37(11):1876-1882; 1996</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> </span><span style="font-family: 'Times New Roman';"> The AECOM/CUMC Collaborative Hypertension Group consists of Blaufox MD, <span style="text-decoration: underline;">Fine EJ</span>, Heller SH, Hurley J, Jagust M, Li Yi, Mann S, Pickering T, Rackson M, Rottman GA, Sarkar S, Zanzonico P, Zhang CG: Simultaneous OIH and DTPA Captopril Renography in Essential Hypertension: The Einstein/Cornell Collaborative Hypertension Study <span style="text-decoration: underline;">in</span> Radionuclides in Nephrourology, (Taylor A, Nally JV, Thomsen H, eds.). Society of Nuclear Medicine, Reston, Va. pp.77-81, 1997.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> </span><span style="font-family: 'Times New Roman';"> The AECOM/CUMC Collaborative Hypertension Group consists of Blaufox MD, <span style="text-decoration: underline;">Fine EJ</span>, Heller SH, Hurley J, Jagust M, Li Yi, Mann S, Pickering T, Rackson M, Rottman GA, Sarkar S, Zanzonico P, Zhang CG: Captopril Renography in Hypertensives with Diminished Renal Function: The Einstein/Cornell Collaborative Hypertension Study <span style="text-decoration: underline;">in</span> Radionuclides in </span><span style="font-family: 'Times New Roman';">Nephrourology, (Taylor A, Nally JV, and Thomsen H, eds. Society of Nuclear Medicine, Reston, Va. pp.72-86,1997.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> </span><span style="font-family: 'Times New Roman';"><span style="font-weight: normal; line-height: normal; font-size: 7.0pt; font-variant: normal; font-style: normal; font-family: 'Times New Roman';"> </span></span><span style="font-family: 'Times New Roman';">Yi Li, Blaufox MD, <span style="text-decoration: underline;">Fine EJ</span> on behalf of the Einstein/Cornell Collaborative Study of Renovascular Hypertension: Effect of Captopril on Renal Mean Transit Time (MTT) in Patients with Essential Hypertension (EH) <span style="text-decoration: underline;">in</span> Radionuclides in Nephrourology, (Taylor A, Nally JV, and Thomsen H, eds.), Society of Nuclear Medicine, pp. 82-87,1997.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> Taylor Jr.A, Fletcher JW, Nally J, Blaufox MD, Dubovsky E, <span style="text-decoration: underline;">Fine EJ</span>, Kahn D, Morton K, Russel C, Sfakianakis G: Society of Nuclear Medicine Procedure Guideline for Diagnosis of Renovascular Hypertension. Published by the Society of Nucl</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> <span style="font-weight: normal; line-height: normal; font-size: 7.0pt; font-variant: normal; font-style: normal; font-family: 'Times New Roman';"> </span></span><span style="font-family: 'Times New Roman';">The Einstein/Cornell Collaborative Hypertension Group-Blaufox MD (Chairman), <span style="text-decoration: underline;">Fine EJ</span>, Heller SH, Hurley J, Jagust M, Li Yi, Mann SJ, Pickering TG, Zanzonico P, Zhang CG. Writing Committee- <span style="text-decoration: underline;">Fine EJ</span> (Chairman), Blaufox, MD, Yi Li, Mann SJ. Prospective Study of Simultaneous Orthoiodohippurate and Diethylenetriaminepentaacetic Acid Captopril Renography. J Nucl Med 39:522-528, 1998</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> <span style="font-weight: normal; line-height: normal; font-size: 7.0pt; font-variant: normal; font-style: normal; font-family: 'Times New Roman';"> </span></span><span style="text-decoration: underline;"><span style="font-family: 'Times New Roman';">Fine EJ</span></span><span style="font-family: 'Times New Roman';">, Li Yi, and Blaufox MD: Parenchymal Mean Transit Time Analysis of 99mTc-DTPA Captopril Renography. J Nucl Med 41:1627-1631, 2000</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"><span style="font-weight: normal; line-height: normal; font-size: 7.0pt; font-variant: normal; font-style: normal; font-family: 'Times New Roman';"> </span></span><span style="font-family: 'Times New Roman';">Lee M, Zuckier L, Zalta B, <span style="text-decoration: underline;">Fine EJ</span>: “The Persistently Absent Bowel Loop A Sign of Mass Effect on the Bowel Detected by Cholescintigraphy”. Clinical Nuclear Medicine 26(11): 939-940, 2001</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> </span><span style="font-family: 'Times New Roman';"><span style="font-weight: normal; line-height: normal; font-size: 7.0pt; font-variant: normal; font-style: normal; font-family: 'Times New Roman';"> </span></span><span style="font-family: 'Times New Roman';">Feinman R, <span style="text-decoration: underline;">Fine EJ</span>: Thermodynamics and metabolic advantage of reducing diets. Metabolic Syndrome and Related Disorders 1(3): 209-219, 2003</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> </span><span style="font-family: 'Times New Roman';"><span style="font-weight: normal; line-height: normal; font-size: 7.0pt; font-variant: normal; font-style: normal; font-family: 'Times New Roman';"> </span></span><span style="font-family: 'Times New Roman';">Feinman RD, </span><span style="text-decoration: underline; font-family: 'Times New Roman';">Fine EJ</span><span style="font-family: 'Times New Roman';">: “A calorie is a calorie violates the second law of thermodynamics.” Nutrition Jl. 3: 9-13, 2004</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> </span><span style="font-family: 'Times New Roman';"><span style="font-weight: normal; line-height: normal; font-size: 7.0pt; font-variant: normal; font-style: normal; font-family: 'Times New Roman';"> </span></span><span style="text-decoration: underline; font-family: 'Times New Roman';">Fine EJ,</span><span style="font-family: 'Times New Roman';"> Feinman RD: Thermodynamics of weight loss diets. Nutrition and Metabolism. 1:15, 2004 (open access: </span><span style="font-family: 'Times New Roman'; layout-grid-mode: both;">http://www.nutritionandmetabolism.com/content/1/1/15</span><span style="font-family: 'Times New Roman';"> )</span></p>
<p style="text-autospace: none;"><span style="font-family: 'Times New Roman';"> </span><span style="font-family: 'Times New Roman';"><span style="font-weight: normal; line-height: normal; font-size: 7.0pt; font-variant: normal; font-style: normal; font-family: 'Times New Roman';"> </span></span><span style="font-family: 'Times New Roman';">Feinman RD, </span><span style="text-decoration: underline; font-family: 'Times New Roman';">Fine EJ</span><span style="font-family: 'Times New Roman';">: Non-equilibrium thermodynamics and energy efficiency in weight loss diets. Theoretical Biology and Medical Modeling. In review, 2007 </span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> </span><span style="font-family: 'Times New Roman';"> <span style="text-decoration: underline;">Fine EJ</span>, Blaufox MD: Quantitation of renal function. Current Concepts in Diagnostic Nuclear Medicine 1(3):12-17, 1984.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> </span><span style="font-family: 'Times New Roman';"> Blaufox MD, <span style="text-decoration: underline;">Fine EJ</span>, Lee H-B, Scharf S: The role of nuclear medicine in clinical urology and nephrology. J.Nucl.Med. 25(5):619-625, 1984.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> <span style="text-decoration: underline;">Fine EJ</span>, Scharf SC, Blaufox MD: The role of nuclear medicinein evaluating the hypertensive patient <span style="text-decoration: underline;">In</span> Nuclear Medicine Annual (1984), Freeman LM and Weissmann HW (eds.), pp.23-79, Raven Press, New York, 1984.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> </span><span style="font-family: 'Times New Roman';"> <span style="text-decoration: underline;">Fine EJ</span>, Axelrod M, Blaufox MD: Physiologic aspects of diagnostic renal imaging. Sem.Nephr. 5(3):188-206, 1985.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> Blaufox MD, <span style="text-decoration: underline;">Fine EJ</span>, Sherman R, Scharf S: Nephrological applications of radionuclide <span style="text-decoration: underline;">In</span> Nuclear Medicine in Urology and Nephrology, 2nd edition, O'Reilly PH, Schields RA,</span><span style="font-family: 'Times New Roman';">Testa HJ (eds.), pp.181-202, Butterworths, London, 1986.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"><span style="font-weight: normal; line-height: normal; font-size: 7.0pt; font-variant: normal; font-style: normal; font-family: 'Times New Roman';"> </span></span><span style="text-decoration: underline;"><span style="font-family: 'Times New Roman';">Fine EJ</span></span><span style="font-family: 'Times New Roman';">: Parathyroid imaging, its' current status and future role. Sem.Nucl.Med.</span><span style="font-family: 'Times New Roman';">XVII(4):350-359,1987.</span></p>
</div>
<p><span style="font-family: 'Times New Roman';"> Kim CK, <span style="text-decoration: underline;">Fine EJ</span>, Blaufox MD: Nonvisualization of both kidneys with I-131 orthoiodohippurate scintigraphy. Sem.Nucl.Med. 18:68-70, 1988.</span></p>
<div>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> <span style="text-decoration: underline;">Fine EJ</span> and Sarkar S: Differential diagnosis of renovascular hypertension through nuclear medicine techniques. Sem.Nucl.Med. XIX, 2:101-115, 1989.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> <span style="text-decoration: underline;">Fine EJ</span>, Blaufox MD: Urological applications of radionuclides <span style="text-decoration: underline;">In</span> Clinical Urography, Pollack H (ed) pp. 518-557, W.B.Saunders, 1990.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> Blaufox MD, <span style="text-decoration: underline;">Fine EJ</span>: Role of nuclear medicine techniques for evaluating hypertensive disease <span style="text-decoration: underline;">In</span> Hypertension: Pathophysiology, Diagnosis and Management. JH Laragh and BM Brenner (eds.), Raven Press, Ltd., pp.1509-1534, 1990.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> <span style="text-decoration: underline;">Fine EJ</span>, Britton KE, Nimmon CE: The scintirenogram in hypertensive disease <span style="text-decoration: underline;">In</span> Evaluation of Renal Function andDisease with Radionuclides, 2nd edition, Blaufox MD (ed.),Karger, Basel, Switzerland, pp.198-247, 1990.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> <span style="text-decoration: underline;">Fine EJ</span>: Assessment of acute and chronic renal failure <span style="text-decoration: underline;">In</span>Evaluation of Renal Function and Disease with Radionuclides, 2nd edition, Blaufox MD (ed), Karger, Basel, pp.316-349, 1990.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> </span><span style="font-family: 'Times New Roman';"> <span style="text-decoration: underline;">Fine EJ</span>: Interventions in Renal Scintirenography. Sem.Nucl. Med. Vol. XXI, 2:116-127, 1991.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> </span><span style="font-family: 'Times New Roman';"> Nally,Jr. JV, Chen C, <span style="text-decoration: underline;">Fine EJ</span>, Ghione S, Geyskes GG, Hoffer P, Sfakianakis G: Diagnotic </span><span style="font-family: 'Times New Roman';">criteria of renovascular hypertension with captopril renography: A consensus statement Amer.J.Hypertension, Vol.4:749S-752S, 1991.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> <span style="text-decoration: underline;">Fine EJ:</span> Nuclear Medicine Evaluation of Hypertension. Urologic Radiology 14:85-95, Springer-Verlag, 1992.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"><span style="font-weight: normal; line-height: normal; font-size: 7.0pt; font-variant: normal; font-style: normal; font-family: 'Times New Roman';"> </span></span><span style="text-decoration: underline;"><span style="font-family: 'Times New Roman';">Fine EJ:</span></span><span style="font-family: 'Times New Roman';"> Vascular disorders, with emphasis on hypertension <span style="text-decoration: underline;">In</span> "Nuclear Medicine in Clinical Diagnosis and Treatment", Murray I and Ell P, eds., Churchill Livingston, London. pp.295-317, 1994.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> Blaufox MD, Middleton ML, <span style="text-decoration: underline;">Fine EJ</span>: Role of Nuclear Medicine Techniques for Evaluating Hypertensive Disease <span style="text-decoration: underline;">In</span> Hypertension: Pathophysiology, Diagnosis, and Management. 2nd edition. JH Laragh and BM Brenner (eds.), Raven Press, New York, pp.2005-2054, 1995.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> <span style="text-decoration: underline;">Fine EJ:</span> Vascular disorders, with emphasis on hypertension <span style="text-decoration: underline;">In</span> "Nuclear Medicine in Clinical Diagnosis and Treatment", Murray I and Ell P, eds., Churchill Livingston, 2nd edition; pp.315-337, 1998.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> <span style="text-decoration: underline;">Fine EJ</span>: Interventions in Renal Scintigraphy. Sem.Nucl.Med. 23(2):128-145, 1999.</span></p>
</div>
<div>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> Prigent A, Cosgriff P, Gates GF, Granerus G, <span style="text-decoration: underline;">Fine EJ</span>, Itoh K, Peters M, Piepsz A, Rehling </span><span style="font-family: 'Times New Roman';">M, Rutland M, and Taylor Jr A: Consensus Report on Quality Control of Quantitative Measerements of Renal Function Obtained From the Renogram: International Consensus Committee From the Scientific Committee of Radionuclides in Nephrourology. Sem.Nucl.Med. 23(2):146-159, 1999.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> <span style="text-decoration: underline;">Fine EJ</span>, Blaufox MD, Rossleigh MA: Urological applications of radionuclides <span style="text-decoration: underline;">In</span> Clinical Urography, Pollack H, McClennan BL, (eds), W.B.Saunders, 2nd edition, pp.621-660, 2000.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"><span style="font-weight: normal; line-height: normal; font-size: 7.0pt; font-variant: normal; font-style: normal; font-family: 'Times New Roman';"> </span></span><span style="text-decoration: underline;"><span style="font-family: 'Times New Roman';">Fine EJ</span></span><span style="font-family: 'Times New Roman';">, Blaufox MD: “Renal Scintigraphy: Update”. Applied Radiology. 1-6, 2001 (January).</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> <span style="text-decoration: underline;">Fine EJ</span>:”Diuretic renography and Angiotensin converting enzyme inhibitor renography.” Radiology Clinics of North America. </span><span style="font-family: 'Times New Roman';">39(5):978-995, 2001.</span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> .<span style="font-weight: normal; line-height: normal; font-size: 7.0pt; font-variant: normal; font-style: normal; font-family: 'Times New Roman';"> </span></span><span style="text-decoration: underline;"><span style="font-family: 'Times New Roman';">Fine EJ</span></span><span style="font-family: 'Times New Roman';">, Zsabo S: “Vascular disorders with emphasis on hypertension”: Chapter in “Nuclear Medicine in Clinical Diagnosis and Treatment” Ell & Gambhir(eds); Churchill Livingston, 3<sup>rd</sup> edition, 2004</span></p>
<p style="text-align: justify;"> <span style="text-decoration: underline;">Fine EJ</span>, Lee D-E, Hawkins M: Sweet Clarity: Less Invasive Measures of Hepatic Glucose Metabolism. Gastroenterology, 2007: 132(2):794-797.</p>
</div>
<div>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"><span style="font-weight: normal; line-height: normal; font-size: 7.0pt; font-variant: normal; font-style: normal; font-family: 'Times New Roman';"> </span></span><span style="text-decoration: underline; font-family: 'Times New Roman';">Fine E</span><span style="font-family: 'Times New Roman';">, Feinman R, Isasi C, Wylie-Rosett J: A new systematic review of low carbohydrate diets. Obesity Research 12 (Supplement): A59 (223-P), 2004</span></p>
<p style="text-align: justify;"> </p>
<p style="text-align: justify;"> </p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> </span></p>
<p style="text-align: justify;"> </p>
<p style="text-align: justify;"> </p>
<p style="text-align: justify;"> </p>
</div>
<p><span style="text-decoration: underline;"><span style="layout-grid-mode: line; font-size: 12.0pt; font-family: 'Times New Roman';"><br style="page-break-before: always;" clear="all" /></span></span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> </span></p>
<p style="text-align: justify;"><span style="font-family: 'Times New Roman';"> </span></p>
